Antibiotics: When Your Blood Test Says You Need Them and When It Doesn't

Antibiotic overuse is one of the most documented and most consequential problems in modern medicine. Resistance development is the headline concern — each course creates selection pressure for resistant variants across the population. But there is a more immediate, individual cost: antibiotics prescribed for viral infections treat nothing while exposing you to side effects and disrupting your microbiome for weeks.

Knowing what your blood test results mean when you're sick puts you in a position to have a real conversation about whether antibiotics are the appropriate tool.

Viral vs. Bacterial Infection: The Clinical Distinction

The immune response differs systematically between viral and bacterial infections, and those differences are visible on a standard complete blood count (CBC) with differential.

White blood cell count (WBC / leukocytes): Total count alone is insufficient. Both bacterial and viral infections can elevate WBC. The differential — the proportion of each leukocyte subtype — is where the meaningful distinction lies.

Lymphocytes are the primary responders to viral infection. They proliferate in response to viral antigens because the adaptive immune system (T and B cells, both lymphocytes) is the primary antiviral defense. A viral infection typically produces a relative or absolute lymphocytosis — elevated lymphocyte percentage relative to total leukocytes.

Neutrophils are the primary responders to bacterial infection. They are phagocytes — they engulf and destroy bacteria. Bacterial infection stimulates rapid neutrophil production from bone marrow, typically producing neutrophilia (elevated neutrophil count and percentage), often with band cells: immature neutrophils released early from bone marrow. This is the "left shift" — a marker of severe or rapidly progressing infection.

> 📌 Defining test: The neutrophil-to-lymphocyte ratio (NLR) is a well-validated marker distinguishing bacterial from viral infection. An NLR >3.5 in an acutely ill patient has a sensitivity of approximately 75–80% and specificity of 60–70% for bacterial infection — useful diagnostic context, not a definitive answer. Values <3.5 in the context of elevated total WBC strongly suggest viral etiology. [1]

C-Reactive Protein (CRP)

CRP is an acute-phase reactant produced by the liver in response to IL-6 signaling, released by macrophages during serious infection. It rises faster and reaches higher levels in bacterial infections than in most viral ones.

Reference ranges vary by laboratory, but typical clinical interpretation:

• CRP < 10 mg/L: bacterial infection unlikely
• CRP 10–40 mg/L: possible bacterial infection or moderate viral infection; clinical judgment required
• CRP > 40 mg/L: bacterial infection substantially more likely

CRP alone is not diagnostic — it is also elevated in autoimmune disease, trauma, and severe viral infections including COVID-19 — but in acute respiratory illness it narrows the differential considerably.

ESR (Erythrocyte Sedimentation Rate)

The older, slower acute-phase marker. ESR rises over 24–48 hours; CRP rises within 6–12. ESR also stays elevated longer after resolution. For acute illness, CRP is more informative because of its faster kinetics. ESR has more utility in monitoring chronic inflammatory conditions.

When Antibiotics Are Indicated

• Confirmed bacterial infection (per blood test, culture, or strong clinical evidence)
• Streptococcal pharyngitis (strep throat — bacterial, responds to antibiotics, risk of rheumatic fever without treatment)
• Bacterial pneumonia (elevated temperature, consolidation on imaging, bacterial differential on CBC)
• Bacterial sinusitis persisting beyond 10 days with worsening symptoms
• Urinary tract infections (with positive dipstick or culture)

Not indicated:

• Common cold (rhinovirus — entirely viral)
• Most acute respiratory infections within the first 7–10 days
• Influenza (viral — antivirals such as oseltamivir may apply; antibiotics do not)
• Most pharyngitis (60–80% is viral)

The Microbiome Consequence

A standard 7–10 day course of broad-spectrum antibiotics substantially reduces gut microbiome diversity. Recovery to pre-antibiotic diversity typically takes 1–2 months; broader-spectrum agents take longer, and some species may not return to pre-treatment levels. Probiotic use during and after antibiotic courses has modest but documented benefit for maintaining diversity and reducing antibiotic-associated diarrhea.

---